Fulcrum Therapeutics (FULC)
Maintains small-molecule gene-regulation capabilities while reviewing strategic alternatives.
$3.89
Pre-market+0.04 (+1.17%)
At close$3.85(−0.65%)
Something off on this page? Send us feedback.
Next report
Oct 29, 2026
in 56 days
EPS estimate
−$0.13
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
May '25Jul '25Oct '25Feb '26Apr '26Jul '26Jul '26Oct '26
Reported−$0.28−$0.28−$0.31−$0.31−$0.25−$0.21−$0.34Pending
Estimate−$0.29−$0.29−$0.29−$0.31−$0.31−$0.24−$0.24−$0.13
Surprise+3.4%+3.4%−6.9%0.0%+19.4%+13.7%−39.7%—
RevenueReportedEstimate
May '25Jul '25Oct '25Feb '26Apr '26Jul '26Jul '26Oct '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct 2026 | −$0.13 | — | — |
| Jul 2026 | −$0.24 | −$0.34 | −39.7% |
| Jul 2026 | −$0.24 | −$0.21 | +13.7% |
| Apr 2026 | −$0.31 | −$0.25 | +19.4% |
| Feb 2026 | −$0.31 | −$0.31 | 0.0% |
The latest year is open to everyone — the 31 quarters behind it read with an account. Sign in | |||
| Oct 2025 | |||
| Jul 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Oct 29, 2026 | −$0.13 | — | — | — | — | — | — |
| Jul 31, 2026 | −$0.24 | −$0.34 | −39.7% | — | — | — | +3.6% |
| Jul 30, 2026 | −$0.24 | −$0.21 | +13.7% | — | — | — | +2.8% |
| Apr 27, 2026 | −$0.31 | −$0.25 | +19.4% | — | — | — | −3.6% |
| Feb 24, 2026 | −$0.31 | −$0.31 | 0.0% | — | — | — | +4.7% |
The latest year is open to everyone — the 31 quarters behind it read with an account. Sign in | |||||||
| Oct 29, 2025 | |||||||
| Jul 29, 2025 | |||||||
| May 1, 2025 | |||||||
| Feb 25, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Jul 31, 2024 | |||||||
| May 13, 2024 | |||||||
| Feb 27, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 9, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 9, 2022 | |||||||
| Mar 3, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 6, 2021 | |||||||
| Mar 4, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Aug 11, 2020 | |||||||
| May 13, 2020 | |||||||
| Mar 5, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 26, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
